Ikena Oncology Inc. (IKNA)
1.29
-0.05 (-3.73%)
At close: Mar 03, 2025, 12:12 PM
Ikena Oncology Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 9.16M | 15.62M | 30.98M | 9.19M | 13.75M | 990K |
| Cost of Revenue | 1.02M | 2.03M | 47.11M | 44.85M | 24.94M | 38.99M |
| Gross Profit | 8.14M | 13.58M | -16.12M | -35.65M | -11.19M | -38M |
| Operating Income | -75.42M | -70.9M | -34.14M | -44.52M | -18.49M | -40.89M |
| Interest Income | 7.11M | 2.15M | 23K | n/a | n/a | n/a |
| Pretax Income | -68.33M | -68.77M | -34.12M | -44.26M | -16.82M | -40.87M |
| Net Income | -68.17M | -66.63M | -34.12M | -44.26M | -16.82M | -40.87M |
| Selling & General & Admin | 24.93M | 22.2M | 18.02M | 8.87M | 7.31M | 2.9M |
| Research & Development | 59.65M | 64.32M | 47.11M | 44.85M | 24.94M | 38.56M |
| Other Expenses | n/a | -10K | 23K | 263K | 1.68M | n/a |
| Operating Expenses | 84.58M | 86.52M | 65.12M | 53.71M | 32.24M | 41.46M |
| Interest Expense | n/a | 2.15M | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 84.58M | 86.52M | 65.12M | 53.71M | 32.24M | 41.88M |
| Income Tax | -162K | -2.14M | 307.44K | 93.7K | 71.14K | n/a |
| Shares Outstanding (Basic) | 41.74M | 36.19M | 35.98M | 35.85M | 35.85M | 35.85M |
| Shares Outstanding (Diluted) | 41.74M | 36.19M | 35.98M | 35.85M | 35.85M | 35.85M |
| EPS (Basic) | -1.63 | -1.84 | -0.95 | -1.23 | -0.47 | -1.14 |
| EPS (Diluted) | -1.63 | -1.84 | -0.95 | -1.23 | -0.47 | -1.14 |
| EBITDA | -74.4M | -70.15M | -33.59M | -44.22M | -18.25M | -40.44M |
| Depreciation & Amortization | 1.02M | 2.03M | 1.72M | 1.26M | 122K | 422K |